Novartis (Bangladesh) Limited Sustainability Profile
Novartis (Bangladesh) Limited, a subsidiary of the global healthcare leader Novartis AG, is headquartered in Dhaka, Bangladesh. Established in 1994, the company has made significant strides in the pharmaceutical industry, focusing on innovative medicines and healthcare solutions. With a strong presence in major operational regions across Bangladesh, Novartis is dedicated to improving patient outcomes through its diverse portfolio. The company’s core products include prescription medications in areas such as oncology, cardiology, and immunology, distinguished by their cutting-edge research and development. Novartis (Bangladesh) Limited has earned a notable market position, recognised for its commitment to quality and patient-centric approaches. With a legacy of innovation and a focus on sustainable healthcare, Novartis continues to play a pivotal role in the advancement of medical science in Bangladesh.
DitchCarbon Score
How does Novartis (Bangladesh) Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Novartis (Bangladesh) Limited's score of 100 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Novartis (Bangladesh) Limited currently does not have specific carbon emissions data available for the most recent year, as indicated by the absence of emissions figures. However, the company is part of a broader corporate family that includes Novartis AG, which has established significant climate commitments and reduction initiatives. As a current subsidiary of Novartis AG, Novartis (Bangladesh) Limited inherits its climate strategies and targets. Novartis AG has set ambitious science-based targets (SBTi) aimed at reducing greenhouse gas emissions across its operations. These targets encompass Scope 1, 2, and 3 emissions, reflecting a comprehensive approach to climate action. While specific reduction targets for Novartis (Bangladesh) Limited are not detailed, the overarching commitments from Novartis AG include initiatives under the Carbon Disclosure Project (CDP), RE100, and the Race to Zero (RTZ) campaign. These initiatives demonstrate a commitment to achieving net-zero emissions and transitioning to renewable energy sources. In summary, while Novartis (Bangladesh) Limited does not report specific emissions data, it aligns with the climate commitments and reduction strategies set forth by its parent company, Novartis AG, reflecting a strong dedication to sustainability and climate action within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 583,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 922,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | - | 0,000,000,000 | 0,000,000,000 | 000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Novartis (Bangladesh) Limited's Industry?
How Carbon Intensive is Novartis (Bangladesh) Limited's Location?
Novartis (Bangladesh) Limited's Scope 3 Categories Breakdown
Novartis (Bangladesh) Limited's Scope 3 emissions, which decreased by 5% last year and increased significantly since 2013, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 78% of Scope 3 emissions.
Top Scope 3 Categories
Novartis (Bangladesh) Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Novartis (Bangladesh) Limited has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Let us know if this data was useful to you
Usage Policy
You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.